Trials / Conditions / Solid Malignancy
Solid Malignancy
6 registered clinical trials studyying Solid Malignancy — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | Romiplostim in Chemotherapy-Induced Thrombocytopenia NCT06201663 | Ain Shams University | Phase 3 |
| Enrolling By Invitation | A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies NCT06208878 | CRISPR Therapeutics AG | — |
| Unknown | Geriatric Oncology Surgical Assessment and Functional rEcovery After Surgery NCT03299270 | AUSL ROMAGNA | — |
| Terminated | PET Imaging of Subjects Using 124I-PU-AD NCT03371420 | Samus Therapeutics, Inc. | EARLY_Phase 1 |
| Completed | Everolimus in Patients With Advanced Solid Malignancies With TSC1, TSC2, NF1, NF2, or STK11 Mutations NCT02352844 | Washington University School of Medicine | Phase 2 |
| Active Not Recruiting | A Phase I Study: PET Imaging of Cancer Patients Using [18F] 4-L-Fluoroglutamine (2S,4R) NCT01697930 | Memorial Sloan Kettering Cancer Center | Phase 1 |